I'm perplexed. The data was far better than I
Post# of 148181
(Total Views: 605)
Posted On: 08/11/2020 2:17:45 PM
I'm perplexed.
The data was far better than I was expecting. A bit surprised that Day 14 data was more significant than Day 3. Additional data was generated that was statistically significant (<.05). I agree w/ TechGuru's analysis. This bodes very well for the severe trial. JL stated as much.
Yet, once again, the PR seems to miss the mark. So I agree w/ gbonation as well. It failed to bring it home. Where's the promotion of the 64% reduction in SAE's they've been touting at every opportunity. Was that not statistically significant and worthy of emphasis here??? How many times did we hear that this data point proved efficacy? It wasn't in the first PR and it wasn't in today's. Inexcusable.
I think emphasis on the fact it was a short, small trial in a population already statistically proven to improve on their own has been lost somewhere. IIRC, these weren't even patients admitted to hospitals.
I also find it inexcusable to release data this important and schedule the conference call for the next day, after the market closes. If someone couldn't make it, they should have held the PR for another day or gone on without them and held a second call/ProActive event later.
The data was far better than I was expecting. A bit surprised that Day 14 data was more significant than Day 3. Additional data was generated that was statistically significant (<.05). I agree w/ TechGuru's analysis. This bodes very well for the severe trial. JL stated as much.
Yet, once again, the PR seems to miss the mark. So I agree w/ gbonation as well. It failed to bring it home. Where's the promotion of the 64% reduction in SAE's they've been touting at every opportunity. Was that not statistically significant and worthy of emphasis here??? How many times did we hear that this data point proved efficacy? It wasn't in the first PR and it wasn't in today's. Inexcusable.
I think emphasis on the fact it was a short, small trial in a population already statistically proven to improve on their own has been lost somewhere. IIRC, these weren't even patients admitted to hospitals.
I also find it inexcusable to release data this important and schedule the conference call for the next day, after the market closes. If someone couldn't make it, they should have held the PR for another day or gone on without them and held a second call/ProActive event later.
(2)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼